GlucoTrack (GCTK) vs Profusa (PFSA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
GlucoTrack is the larger company by market cap ($1.1 million vs $902,414), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GCTK | PFSA |
|---|---|---|
| Share price | $1.11 | $1.49 |
| Market cap | $1.13M | $902.41K |
| 1-day change | -3.48% | -0.67% |
| P/E ratio (TTM) | — | 0.00 |
| EPS (TTM) | $-123.15 | $897.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $123.75 | $3,000.00 |
| 52-week low | $1.07 | $1.42 |
| Distance from 52-week high | -99.10% | -99.95% |
| Average volume | 2.06M | 2.74M |
| Shares outstanding | 1.02M | 605.65K |
| Employees | 15 | — |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About GlucoTrack
GCTK stock →GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Health Care · Medical/Dental Instruments · 15 employees
About Profusa
PFSA stock →Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery.
Health Care · Medical/Dental Instruments
GCTK vs PFSA FAQ
Which is bigger, GlucoTrack or Profusa?
GlucoTrack (GCTK) is larger, with a market capitalization of $1.13M compared with $902.41K for Profusa (PFSA).
Are GlucoTrack and Profusa in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.